|
Characteristics at ICU admission
| | | |
|
Age
|
40 ± 9
|
42 ± 9
|
0.19
|
|
Sex (M/F)
|
8/17
|
19/36
|
0.99
|
|
SAPSII on admission
|
55 ± 25
|
42 ± 16
|
0.02
|
|
Glasgow on admission
|
10 ± 5
|
13 ± 4
|
0.05
|
|
HIV infection
| | | |
|
Initial HIV diagnosis
|
8 (32)
|
6 (11)
|
0.03
|
|
Stage C
|
20 (80)
|
43 (78)
|
0.99
|
|
CD4 count at admission (/mm3)
|
154 ± 201
|
215 ± 198
|
0.21
|
|
AIDS related diagnosis at ICU admission
|
16 (64)
|
24 (44)
|
0.15
|
|
Care in ICU
| | | |
|
Mechanical ventilation
|
19 (76)
|
20 (36)
|
0.0015
|
|
Duration of ventilation (days)
|
10 ± 13
|
3 ± 8
|
0.0001
|
|
Vasoactive drugs
|
6 (24)
|
5 (9)
|
0.09
|
|
Duration of vasoactive drugs use (days)
|
1.7 ± 2.5
|
0.6 ± 1.3
|
0.006
|
|
Use of HAART
| | | |
|
HAART at ICU admission
|
11 (44)
|
35 (64)
|
0.14
|
|
immunovirological success at ICU admission
|
3 (12)
|
17 (31)
|
0.096
|
|
HAART during ICU stay
|
9 (36)
|
21 (38)
|
0.99
|
